Sovereign Global Advisors End the Year on the Right Foot



Sovereign Global Advisors wrapped up a busy year by keeping those affected by cystic fibrosis, a life-threatening genetic disease, in mind. President and CEO, John Dragotta, made a contribution to the Cystic Fibrosis Foundation in order to join in their mission of finding a cure as well as fund the research and development of drugs and individualized treatment with high quality, specialized care that will help people with the disease live full and productive lives. In 2014, the foundation raised awareness and nearly $4 million towards making CF a thing of the past.

The Cystic Fibrosis Foundation funds more innovative, groundbreaking CF research than any other organization in the world. They have invested hundreds of millions of dollars into CF research and drug development. The results of these bold investments have been astonishing. Because of their efforts, people with cystic fibrosis are living longer, healthier lives and pursuing dreams they never before thought possible. To learn more and how you can make a difference, please visit www.cff.org

At Sovereign Global Advisors, we look for success in a very crowded financial field by applying our extensive experience investing in opportunities around the world and managing investments for corporations and high-net worth families. We use an established blend of people power, industry savvy, and access to global markets to assist us in reaching our vision not only for our clients but also for our company and community at large. Our success, this company’s success, is undoubtedly intertwined with the success of all our clients. We will never forget this. For more information on Sovereign’s services and philanthropy efforts, please visit our philanthropy page.